John H. Griffin

Phd
Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA
San Diego, California, United States

Presentation(s):

• OC 49.1 - 3K3A-Activated Protein C treatment exerts anti-inflammatory and blood barrier stabilizing effects in the retina, and inhibits choroidal neovascularization

  Monday, June 26, 2023
  14:45 – 15:00 ET

• PB0592 - Evaluation of the Role of Skeletal Muscle Myosin as a Cofactor for Factor XI Activation of Factor XII

  Monday, June 26, 2023
  18:30 – 19:30 ET

• PB1433 - Opposing effects of canonical and non-canonical PAR-1 activation in experimental diet-induced obesity and fatty liver disease

  Tuesday, June 27, 2023
  18:30 – 19:30 ET

• PB1435 - Canonical activation of protease-activated receptor-1 drives experimental liver fibrosis

  Tuesday, June 27, 2023
  18:30 – 19:30 ET